Study Finds Quality of the Psychedelic Experience is Important for Effective Psilocybin Therapy

Study finds that the quality of psychedelic experience from psilocybin can predict how effective therapy will be for a patient being treated for treatment-resistant depression.

January 2018

Results of a study done by the Psychedelic Research Group at the Imperial College London were published in Frontiers of Pharmacology. The study showed that the quality of the psychedelic experience brought on by psilocybin predicted how effective the patient’s therapy was for treatment-resistant depression (TRD).